Related Experiment Video
Updated: Mar 16, 2026

Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis
Published on: May 16, 2025
Crystal-Associated Colitis with Ulceration Leading to Hematochezia and Abdominal Pain
Meeta Desai1, Aaron Reiprich2, Nancy Khov3
1Department of Internal Medicine, Penn State Milton S. Hershey Medical Center, Hershey, Pa., USA.
Insights
Medication-associated mucosal injury from ion-exchange resins like sevelamer can cause lower GI bleeding. Discontinuing these drugs resolved a patient's rectal bleeding and abdominal pain, highlighting an underrecognized cause of hematochezia.
Area of Science:
- Gastroenterology
- Nephrology
- Oncology
Background:
- Lower gastrointestinal (GI) bleeding is a frequent reason for adult hospitalization.
- Medication-associated mucosal injury is a significant clinical issue linked to morbidity and mortality.
Observation:
- A 45-year-old woman presented with a 3-month history of abdominal cramping and rectal bleeding.
- Her medical history included end-stage renal disease and prior radiation therapy for endometrial carcinoma.
- Initial evaluations suggested ischemic or radiation colitis, but histology revealed acute inflammation and ulceration with crystal fragments.
Findings:
- Histological findings were consistent with acute inflammation and ulceration attributed to crystal fragments.
- Sevelamer and cholestyramine, common ion-exchange resins, were identified as potential causes of mucosal damage.
- Discontinuation of these medications led to the resolution of the patient's symptoms.
Implications:
- This case underscores the importance of considering medication-induced mucosal injury in patients with lower GI bleeding.
- Ion-exchange resins should be evaluated as a potential etiology for unexplained hematochezia.
- Recognizing this underappreciated cause can prevent misdiagnosis and improve patient outcomes.
Abstract:
Lower GI bleeding is a common cause for hospitalization in adults. Medication-associated mucosal injury is an important clinical entity that can result in significant morbidity and mortality. We present the case of a 45-year-old woman with a 3-month history of intermittent abdominal cramping and rectal bleeding. Her medical history was extensive and included end-stage renal disease and a remote history of endometrial carcinoma that was treated with radiation. Initial workup was concerning for ischemic and radiation colitis, however, histology was most consistent with acute inflammation and ulceration associated with crystal fragments. Sevelamer and cholestyramine are commonly used ion-exchange resins that have been associated with mucosal damage. Both medications were discontinued and her symptoms resolved. Our case highlights an underrecognized but important cause of hematochezia.
Related Concept Videos
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Drugs for Treatment of Ulcerative Colitis in IBD
Assessment of the Rectum and Anus
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...

